PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32074497-7	2020	PAM is highly effective in clarithromycin-resistant cases (70.4% versus 48.2%, RR = 0.65, p = 0.002) and that PAC showed significant efficacy in metronidazole-resistant cases (87.3% versus 58.6%, RR = 1.43, p = 0.0006).	Clarithromycin	27-41	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	0-3	
31881688-9	2019	The overall H. pylori eradication rate was 83.7%, and the seven-day PAM-treated clarithromycin-resistance group showed a significantly lower eradication rate than the seven-day PAC-treated nonresistance group (ITT; 55.4% (51/92) vs. 74.3% (252/339), p = 0.001, PP; 66.2% (51/77) vs. 88.4% (252/285), p = 0.0001).	Clarithromycin	80-94	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	68-71	
31881688-10	2019	CONCLUSIONS: There were significantly lower eradication rates in the patients with clarithromycin-resistant H. pylori when treated with PAM for seven days.	Clarithromycin	83-97	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	136-139	
9386357-4	1997	It was also found that rifamycins in combination with clarithromycin could have a good bactericidal effect in the PAM-model of the infection.	Clarithromycin	54-68	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	114-117